Clinical Breast Cancer

Papers
(The TQCC of Clinical Breast Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial147
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer105
Cancer-related Fatigue in Breast Cancer Survivors: A Review88
Epidemiology of De Novo Metastatic Breast Cancer44
Thermal Ablation as an Alternative for Surgical Resection of Small (≤ 2 cm) Breast Cancers: A Meta-Analysis43
Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study43
Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer43
Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 201942
Circulating Biomarkers in Breast Cancer41
Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression40
Quality of Life and Early Functional Evaluation in Direct-to-Implant Breast Reconstruction After Mastectomy: A Comparative Study Between Prepectoral Versus Dual-Plane Reconstruction31
Regret and Quality of Life After Mastectomy With or Without Reconstruction28
Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial28
nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer28
Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy27
Advances in Combining Radiation and Immunotherapy in Breast Cancer27
Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis26
Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer26
Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis26
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer25
Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses24
MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)24
Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization23
Controversial role of mast cells in breast cancer tumor progression and angiogenesis22
Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI22
MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions21
Rapid Assessment of Resection Margins During Breast Conserving Surgery Using Intraoperative Flow Cytometry20
Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis20
Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer20
Manual Lymphatic Drainage for Breast Cancer-related Lymphedema: A Systematic Review and Meta-analysis of Randomized Controlled Trials20
Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues20
Prevention of Breast Cancer-Related Lymphedema20
Direct to Implant Breast Reconstruction With Prepectoral Micropolyurethane Foam-Coated Implant: Analysis of Patient Satisfaction19
Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer19
Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing19
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach19
Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up19
Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study19
Advances in Therapeutic Approaches for Triple-Negative Breast Cancer19
Breast Lymphedema After Conservative Breast Surgery: An Up-to-date Systematic Review17
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study17
Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA217
Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review17
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors17
Oncologic Safety of Autologous Fat Grafting in Breast Reconstruction16
An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast16
Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data16
Deep Learning for the Detection of Breast Cancers on Chest Computed Tomography16
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)16
Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study15
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPA15
Nomogram Predicting the Risk of Locoregional Recurrence After Mastectomy for Invasive Micropapillary Carcinoma of the Breast15
Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes15
Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer15
Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Liter15
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies15
Neuromuscular, Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients15
Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer14
Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema14
The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis14
Bone-modifying Agents (BMAs) in Breast Cancer14
Nuances of PFKFB3 Signaling in Breast Cancer14
Magnetic Seeds: An Alternative to Wire Localization for Nonpalpable Breast Lesions14
The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based Chemotherapy14
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy14
Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database13
Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression13
Network Meta-analysis for the Diagnostic Approach to Pathologic Nipple Discharge13
Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy13
Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial Cohort13
Predicting Mastectomy Skin Flap Necrosis: A Systematic Review of Preoperative and Intraoperative Assessment Techniques12
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis12
A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy12
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity12
Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy12
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer12
Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?12
Axillary Reverse Mapping in the Prevention of Lymphoedema: A Systematic Review and Pooled Analysis11
Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells11
The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis11
Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database11
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer11
Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer11
Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature11
Effect of Surgery at Primary and Metastatic Sites in Patients With Stage IV Breast Cancer11
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer11
YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer11
Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis11
An individual participant data meta-analysis of breast cancer detection and recall rates for digital breast tomosynthesis versus digital mammography population screening11
Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics11
Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center10
Approaches to Fertility Preservation for Young Women With Breast Cancer10
Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients10
Prospective Clinical Trial on Expanding Indications for Cryosurgery for Early Breast Cancers10
Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study10
RUNX1 as a Novel Molecular Target for Breast Cancer10
Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic10
CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers10
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer10
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions10
Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan10
Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced Mammography10
Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery10
Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study10
Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis10
The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data9
ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer9
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy9
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer9
Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells9
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction9
Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer9
Werner Syndrome Protein Expression in Breast Cancer9
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review9
Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial9
AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer9
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data9
Nomogram Based on Breast MRI and Clinicopathologic Features for Predicting Axillary Lymph Node Metastasis in Patients with Early-Stage Invasive Breast Cancer: A Retrospective Study9
Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT9
The Effects of HER2 on CDK4/6 Activity in Breast Cancer9
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study9
MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer9
Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?9
Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population9
Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis9
A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer9
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study9
First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis9
Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer8
Survival in Women Diagnosed With Breast Cancer During Pregnancy8
Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma8
Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N38
Current Status and Problems of Breast Cancer Treatment with Schizophrenia8
Experiences of Women With Breast Cancer Using Telehealth: A Qualitative Systematic Review8
Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling8
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy8
Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors, and Nomograms for Predicting Survival8
Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison8
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay8
Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users8
Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors8
Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer8
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study8
Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans8
Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program8
Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells8
Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment8
Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey8
The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review8
Rehabilitation for Women Undergoing Breast Cancer Surgery: A Systematic Review and Meta-Analysis of the Effectiveness of Early, Unrestricted Exercise Programs on Upper Limb Function8
Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis8
A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women7
Review of Variables Associated With Positive Surgical Margins Using Scout Reflector Localizations for Breast Conservation Therapy7
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy7
Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01)7
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases7
The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study7
Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy7
FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway7
A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer7
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer7
Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer7
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies7
Improving Decision-making in Prepectoral Direct-to-implant Reconstruction After Nipple Sparing Mastectomy: The Key Role of Flap Thickness Ratio7
Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization7
Extended Clinical Experience With Nipple-Sparing Mastectomy and Prepectoral Polyurethane Implant Positioning (BRAND4P method)7
Validation of CTS5 on a Retrospective Cohort of Real-Life Pre- and Postmenopausal Patients Diagnosed With Estrogen Receptor–Positive Breast Cancers: Is It Prognostic?7
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer7
Diagnostic Performance of PET/MRI in Breast Cancer: A Systematic Review and Bayesian Bivariate Meta-analysis7
Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer7
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer7
Big Data Solutions for Controversies in Breast Cancer Treatment7
Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis7
Tumor-Infiltrating Lymphocytes (TIL), Tertiary Lymphoid Structures (TLS), and Expression of PD-1, TIM-3, LAG-3 on TIL in Invasive and In Situ Ductal Breast Carcinomas and Their Relationship with Progn7
Mitigating Financial Toxicity in Breast Cancer From Diagnosis to Treatment and Reconstruction7
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer6
Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma6
Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions6
Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide6
En Bloc Excision of Phyllodes Tumor of the Breast: Radical Approach Heralds Better Outcome6
A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer6
Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer6
Metaplastic Breast Cancer: Current Understanding and Future Directions6
Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer6
Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy6
Adherence to the DASH Diet and Risk of Breast Cancer6
Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer6
Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-20186
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence6
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)6
Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study6
Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction6
Overall Survival for HER2-Positive Breast Cancer Patients in the HER2-Targeted Era: Evidence From a Population-Based Study6
Characterizing Clinicopathologic Features of Estrogen Receptor-Positive/Progesterone Receptor-Negative Breast Cancers6
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes6
Delayed Diagnosis and Prognostic Impact of Breast Cancer During the COVID-19 Pandemic6
Protection Motivation Theory and Prevention of Breast Cancer: A Systematic Review6
m6A Modification Mediates Exosomal LINC00657 to Trigger Breast Cancer Progression Via Inducing Macrophage M2 Polarization6
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution6
Preoperative MRI for Evaluation of Extent of Disease in IDC Compared to ILC6
USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination6
Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy5
Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of Breast Cancer in Australian Caucasian Women5
Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital5
Patient Reported Outcome and Quality of Life After Delayed Breast Reconstruction - An RCT Comparing Different Reconstructive Methods in Radiated and Non-radiated Patients5
Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors5
Can Women With HER2-Positive Metastatic Breast Cancer Be Cured?5
Oncoplastic Repair in Breast Conservation: Comprehensive Evaluation of Techniques and Oncologic Outcomes of 937 Patients5
Physical Activity Levels of Breast Cancer Patients Before Diagnosis Compared to a Reference Population: A Cross-Sectional Comparative Study5
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients5
Oncoplastic Surgery: Does Patient and Medical Specialty Influences the Evaluation of Cosmetic Results?5
Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery5
Does Immediate Breast Reconstruction Lead to a Delay in Adjuvant Chemotherapy for Breast Cancer? A Meta-Analysis and Systematic Review5
Surgeon Bias in the Management of Positive Sentinel Lymph Nodes5
miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients5
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast Cancer5
De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?5
Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review5
Comparison of 3 Different Systems for Non-wire Localization of Lesions in Breast Cancer Surgery5
lncRNA LINC000466 Predicts the Prognosis and Promotes the Progression of Triple‐negative Breast Cancer via Modulating miR‐539‐5p5
Motor Exercises Effect on Improving Shoulders Functioning, Functional Ability, Quality of Life, Depression and Anxiety For Women With Breast Cancer5
Real-world Evidence of Implementing eHealth Enables Fluent Symptom-based Follow-up of a Growing Number of Patients with Breast Cancer with the Same Healthcare Resources5
The Impact of Limited Language Proficiency in Screening for Breast Cancer5
An Overview of Psychological Analysis of Breast Cancer Patients undergoing Modified Radical Mastectomy and Breast Conservation Surgery and its impact on Objectified Body Consciousness at a Tertiary Ca5
Mode of Detection of Second Events in Routine Surveillance of Early Stage Breast Cancer Patients5
The benefit of superb microvascular imaging and shear wave elastography in differentiating metastatic axillary lymphadenopathy from lymphadenitis5
In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells5
Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study5
Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients5
Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment5
Prospective Analysis Using a Novel CNN Algorithm to Distinguish Atypical Ductal Hyperplasia From Ductal Carcinoma in Situ in Breast5
Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis5
Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery5
Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial5
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From th5
p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study5
Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis5
Breast-conserving Surgery Without Radiation Therapy for Invasive Cancer5
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC5
Relation Between Early Disturbance of lymphatic transport Visualized With Lymphofluoroscopy and Other Clinical Assessment Methods in Patients With Breast Cancer5
A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives5
Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer5
Intraoperative Touch Imprint Cytology in Breast Cancer Patients After Neoadjuvant Chemotherapy5
Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment5
Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features an5
Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy5
Intraoperative Radiotherapy for Breast Cancer in Elderly Women5
Prone Positioning With Deep Inspiration Breath Hold for Left Breast Radiotherapy5
An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline5
Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology5
0.098573923110962